Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-001913-17Phase 3Active
Phase 3, randomised trial of glycerol in low anterior resection syndrome (LARS) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Improvement of main symptom (MYMOP score). Started May 2019; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-001913-17.